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Abstract 
Isochromosome of the short arm of chromosome 5 is 
an infrequent chromosome anomaly that has been 
reported in myeloid, and less frequently in in 
lymphoid malignancies, including leukemia and 
lymphomas. 
Keywords 
AML, acute monoblastic leukemia, isochromosome 
5p, clonal evolution. 
Clinics and pathology 
Disease 
Chronic or acute myeloid malignancies and 
lymphoid neoplasms. 
Note See also i(5)(p10) in acute myeloid leukemia 
Epidemiology 
Chronic myeloproliferative disorders (MPD) in 8 
(4M/4F aged 19 to 81 years; median 66 years): 1 
chronic myeloid leukemia (Markovic et al., 2000) 
and 7 MDS (Christodoulou et al., 2004; Lessard et 
al., 2007; Herry et al., 2010; Jimenez-Sousa et al., 
2010; Douet-Guilbert et al., 2011;  Reddi et al., 2012; 
Giudici et al., 2013). 
Acute myeloid leukemia (AML) in 18 (9M/9F aged 
8 to 86 years, median 64 years): 2 AML (Flach et al., 
2011; Hartmann et al.,2014), 2 acute myeloblastic 
leukemia without maturation (M1) (Calabrese et al., 
2000; Choi et al., 2007), 2 acute myeloblastic 
leukemia with maturation (M2) (Tamura et al., 1998; 
Herry et al., 2007), 1 acute promyelocytic leukemia 
(M3) (Goldschmidt et al., 2010), 2 acute 
myelomonocytic leukemia (M4) (El-Rifai et al., 
1997; Panani 2006), 8 acute monoblastic leukemia 
(M5) (Yunis 1984; Slovak et al., 1991; Schoch et al 
2001; Schmidt et al., 2004;  Gervais et al., 2008; Paar 
et al., 2013) and 1 acute erythroleukemia (M6) 
(Herry et al., 2010) patient.  
Multiple myeloma was diagnosed in a single male 
(Sawyer et al., 2014).  
Lymphoid malignancies in 12 patients. B-cell 
lymphomas in 7 (3M/4F aged 55, 71, 78 and 86 
years, 3 unknown) (Hashimoto et al., 1995; 
Dierlamm et al., 1997; Wlodarska et al., 1999; 
Hernandez et al., 2001; Bastard et al., 1992; Cook et 
al., 2004; Johnson et al., 2008), and there was a 54-
years old male with chronic lymphocytic leukemia 
(Jarosova et al., 2010).   
3 patients were diagnosed with T-cell lymphoid 
malignancies (2M/1F aged 38 and 69 years,  1 
unknown) (Heinonen et al., 1994; Lepretre et al., 
2000; Nelson et al., 2008) and an 11- years old male 
with bilineage or biphenotypic leukemia (La Starza 
et al., 1993). 
Etiology 
38 patients (20 M/18 F aged 8 to 86 years; median 
69 years). Myeloid malignancies mainly (26 
patients): 18 AML, 7 MDS and 1 CML.  
In 10 of the 18 AML patients the cells were of 
monoblastic (8 patients)/monocytic (2 patients) 
lineage.  
Among them, 4 had therapy-related MDS, 1 had 
therapy-related AML (t-MDS/t-AML), and one 
patient had chronic myelogenous leukemia in 
myeloid blast phase. 
The primary diagnoses for patients with t-MDS/t-
AML were mediastinal germ cell tumor 
(Christodoulou et al., 2004), carcinoma of the ovary 
(Lessard et al., 2007), breast carcinoma (Gervais et 
al., 2008) and multiple myeloma (Jimenez-Sousa et 
al., 2010; Reddi et al., 2012).  
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Figure 1. Partial karyotypes with i(5)(p10) (A). Fluorescence in situ hybridization with LSI CSF1R/D5S23, D5S721 probe 
hybridizing to 5p15.2 and 5q33-34 sequences (Abbott Molecular/Vysis, US) showing combination of chromosome 5 
abnormalities: deletion of the long arm of chromosome 5, duplication of 5q33-34 sequences and isochromosome i(5)(p10) (B). 
 
The occurrence of i(5)(p10 was not restricted to 
myeloid malignancies as it was also detected in 8 
patients with B-cell and in 3 with T-cell lymphoid 
malignancies. 
Prognosis 
i(5)(p10 is frequently part of complex karyotypes 
representing clonal evolution that may reflect 
genomic instability. Most of these patients showed a 
more aggressive course of the disease and poor 
response to chemotherapy (Paar et al., 2013). 
Genetics 
Note 
The formation of i(5)(p10) may be observed in two 
patterns:  (1) i(5)(p10) replacing a normal 
chromosome 5 leading to the loss of the long arm of 
chromosome 5 and duplication of its short arm. (2) It 
occurs as a supernumerary +i(5)(p10) chromosome, 
with two normal copies of chromosome 5, resulting 
in 5p tetrasomy, that has been reported in AML and 
B-cell lymphoid malignancies, but not in MDS. 
Cytogenetics 
Note 
Because of their similar cytogenetic appearance, the 
incidence of i(5)(p10) may be underestimated as it 
might have been misinterpreted as 5q deletion, a 
known chromosome abnormality in myeloid 
malignancies. Therefore, to discriminate between 5q 
deletion and i(5)(p10), fluorescence in situ 
hybridization using locus specific probes for 5p/5q 
sequences is recommended. 
Cytogenetics morphological 
Presents as i(5)(p10) resulting in 5q deletion in 7 
MPD, 6 AML, 1 CLL, 1 mature B-cell neoplasm and 
3 T-cell lymphoid malignancies. Among them, sole 
anomaly in 1 MDS (Douet-Guilbert et al., 2011), 
sole additional anomaly to +8 in 1 MDS (Jimenez-
Sousa et al., 2010), to -Y in 1 MDS (Reddi et al., 
2012) and found as +8 and complex karyotypes in 2 
AML (El-Rifai et al., 1997; Herry et al., 2007). In 1 
MDS patient, 2 copies of isochromosome 5p and a 
single normal chromosome 5 have been detected 
(Giudici et al., 2013).Presents as a supernumerary 
+i(5)(p10) in 11 out of 17 AML, in the bilineage or 
biphenotypic leukemia, in 1 MM an in 6 out of 7 B-
cell lymphomas. Among them, +8 was found in 8 
AML patients (Panani 2006; Yunis 1984; Schoch et 
al 2001; Slovak et al., 1991; Calabrese et al., 2000; 
Flach et al., 2011) while it was a sole additional 
anomaly to +8 in 3 patients (Schoch et al 2001; 
Panani 2006). Found with 14q32 rearrangement and 
complex karyotypes in 3 out of 6 B-cell lymphomas 
and as part of complex karyotypes in the remaining 
patients. 




Isochromosome of the short arm of chromosome 5 
represents a rare but recurrent chromosome anomaly 
in hematological malignancies.  
 
Its occurrence has been mainly associated with 
myeloid malignancies, especially AML with 
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monocytic lineage, but it has also been reported in 
lymphoid disorders, including leukemia and 
lymphomas. When present in a single copy, 
i(5)(p10) results in 5p trisomy and 5q monosomy, 
that might be similar to a 5q- syndrome. Therefore, 
loss of material from chromosome 5q arm and gain 
of 5p material may play a key pathogenic role in 
these patients. In contrast, when presents as a 
supernumerary +i(5)(p10) chromosome, the 
formation of isochromosome leads to 5q disomy and 
5p tetrasomy, thus duplication of its short arm 
leading to copy gain imbalances could contribute to 
proliferative advantage of the cells. i(5)(p10) is 
mainly observed as an additional chromosomal 
abnormality to known anomalies such as trisomy 8 
in myeloid malignancies or is part of a complex 
karyotypes, likely representing a secondary 
cytogenetic event in the majority of patients. 
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